Drug Database
A10BB09 gliclazide
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Dacadis MR 30mg Modified-Release Tablets
- POM Diamicron MR 30 mg
- POM Gliclazide 160mg tablets
- POM Gliclazide 40 mg Tablets
- POM Gliclazide 40mg Tablets
- POM Gliclazide 40mg Tablets
- POM Gliclazide 80 mg Tablets
- POM Gliclazide Krka 60 mg modified-release tablets
- POM Gliclazide Milpharm 80mg tablets
- POM Nazdol MR 30 mg modified-release tablets
- POM Vamju 60 mg modified-release tablets
- POM Ziclaseg 30mg prolonged-release tablets.
- POM Zicron 40mg Tablets
- POM Zicron PR 30 mg prolonged-release tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).